USPSTF: Evidence Lacking for Iron Deficiency Screening in Pregnancy
By Elana Gotkine HealthDay Reporter
TUESDAY, Feb. 27, 2024 -- The U.S. Preventive Services Task Force concludes there is currently insufficient evidence regarding screening and supplementation for iron deficiency anemia (IDA) during pregnancy. These findings form the basis of a draft recommendation statement published online Feb. 27.
Amy Cantor, M.D., M.P.H., from the Pacific Northwest Evidence-Based Practice Center at the Oregon Health & Science University in Portland, and colleagues conducted a systematic review on screening and supplementation for IDA and ID without anemia in pregnancy. Seventeen trials of routine maternal iron supplementation that reported outcomes for pregnant persons and infants were included in the review. The researchers found that compared with placebo, prenatal iron supplementation resulted in no differences in maternal quality of life, rates of gestational diabetes, or rates of maternal hemorrhage. Maternal iron supplementation also had no effect on rates of hypertensive disorders of pregnancy, cesarean delivery, preterm birth, infant low birth weight, or infants small for gestational age. No studies examined the benefits or harms of screening for ID or IDA during pregnancy.
Based on these findings, the USPSTF concludes that the current evidence is insufficient for assessing the balance of benefits and harms of screening asymptomatic pregnant adolescents and adults for ID and IDA to prevent adverse maternal and infant health outcomes (I statement). Furthermore, the evidence is insufficient for assessing the balance of benefits and harms of routine iron supplementation in pregnancy for preventing adverse maternal and infant health outcomes (I statement).
The draft recommendation statement and evidence review have been posted for public comment. Comments can be submitted from Feb. 27 through March 25.
Draft Recommendation Statement
Comment on Recommendation Statement
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted February 2024
Read this next
Most Moms-to-Be Interested in RSV Vaccination During Pregnancy
THURSDAY, April 25, 2024 -- More than half of women who are pregnant or planning to become pregnant are very likely to get vaccinated against respiratory syncytial virus (RSV)...
Gestational Weight Gain Below IOM Recommendation Safe in Obesity
FRIDAY, April 5, 2024 -- Gestational weight gain below the current U.S. Institute of Medicine (IOM) recommendation is safe for pregnancies with obesity, according to a study...
One-Quarter of Pregnant Women Rarely, Never Consume Fish
FRIDAY, March 15, 2024 -- About one-quarter of pregnant women rarely or never consume fish during pregnancy, and few use omega-3 supplements, according to a study published online...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.